Aihara M, Takami H, Sawada Y, Morimoto S, Kariya K, Kudo I, Ueno K, Kimura A, Yoshida Y
Thromb Res. 1986 Dec 1;44(5):661-72. doi: 10.1016/0049-3848(86)90167-2.
The adhesion of human fixed washed platelets (FWP) to collagen was measured using collagen immobilized beads. The addition of normal plasma or severe von Willebrand disease (VWD) plasma to FWP decreased the adhesion, suggesting the presence of some inhibitors of platelet adhesion in human plasma. Although the adhesion of FWP in severe VWD plasma was not different from that of FWP in normal plasma, the addition of purified von Willebrand factor (vWF, 1-2 mu/ml ristocetin cofactor) to FWP in buffer increased the FWP adhesion at higher flow rates, and the percent of adhesion in the absence of vWF was 10% (collagen 500 micrograms) and 30% (collagen 1,000 micrograms) of that in the presence of vWF at 10 ml/min. The enhancing effect of the vWF on FWP adhesion was also observed by pretreatment of the collagen column with vWF suggesting the important role of bound vWF to the collagen; adhesion 72% to the collagen column (1,600 micrograms) treated with vWF and 16% to the collagen column without the pretreatment at 10 ml/min. The promoting effect of vWF was also present in some commercial factor VIII preparations which had no large or intermediate multimers of vWF antigen. The adhesion of FWP was inhibited by fibronectin (FN) and the binding of ristocetin cofactor (vWF:RCo) to collagen fiber was also inhibited by FN; bound vWF:RCo to 50 micrograms/ml collagen in the absence or presence of 125 micrograms/ml FN were 60% and 8% respectively. It is suggested that vWF, even small multimer of vWF:Ag, is involved in the initial platelet-collagen interaction at high flow rates, while plasma FN acts as one of anti-adhesion factor.
使用固定化胶原珠测量人固定洗涤血小板(FWP)与胶原的黏附。向FWP中添加正常血浆或重度血管性血友病(VWD)血浆可降低黏附,提示人血浆中存在某些血小板黏附抑制剂。尽管重度VWD血浆中FWP的黏附与正常血浆中FWP的黏附无差异,但在缓冲液中向FWP添加纯化的血管性血友病因子(vWF,1 - 2μg/ml瑞斯托霉素辅因子)可在较高流速下增加FWP的黏附,在无vWF时的黏附百分比在10 ml/min时为有vWF时的10%(胶原500μg)和30%(胶原1000μg)。通过用vWF预处理胶原柱也观察到vWF对FWP黏附的增强作用,提示结合在胶原上的vWF的重要作用;在10 ml/min时,与用vWF处理的胶原柱(1600μg)的黏附率为72%,与未预处理的胶原柱的黏附率为16%。vWF的促进作用在一些不含vWF抗原大或中多聚体的商业因子VIII制剂中也存在。FWP的黏附受纤连蛋白(FN)抑制,FN也抑制瑞斯托霉素辅因子(vWF:RCo)与胶原纤维的结合;在不存在或存在125μg/ml FN时,与50μg/ml胶原结合的vWF:RCo分别为60%和8%。提示vWF,即使是vWF:Ag的小多聚体,在高流速下参与血小板 - 胶原的初始相互作用,而血浆FN作为抗黏附因子之一发挥作用。